{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T14:06:03Z","timestamp":1780409163360,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"United States Agency for International Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.contraception.2015.07.003","type":"journal-article","created":{"date-parts":[[2015,7,18]],"date-time":"2015-07-18T15:34:04Z","timestamp":1437233644000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness"],"prefix":"10.1016","volume":"93","author":[{"given":"Maura K.","family":"Whiteman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1438-2399","authenticated-orcid":false,"given":"Anna","family":"Samarina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Akatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Martirosyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry M.","family":"Kissin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn M.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polly A.","family":"Marchbanks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan D.","family":"Hillis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele G.","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise J.","family":"Jamieson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.contraception.2015.07.003_bb0005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1086\/591697","article-title":"Hormonal contraception and HIV disease progression","volume":"47","author":"Stringer","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.contraception.2015.07.003_bb0010","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1097\/QAD.0b013e32832cbca8","article-title":"HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial","volume":"23","author":"Stringer","year":"2009","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.contraception.2015.07.003_bb0015","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/QAD.0b013e32835bb672","article-title":"Effect of hormonal contraceptive methods on HIV disease progression: a systematic review","volume":"27","author":"Phillips","year":"2013","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.contraception.2015.07.003_bb0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAD.0b013e32835ad473","article-title":"Hormonal contraceptive use and risk of HIV-1 disease progression","volume":"27","author":"Heffron","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2015.07.003_bb0025","series-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach, June 2013","author":"World Health Organization","year":"2013"},{"key":"10.1016\/j.contraception.2015.07.003_bb0030","doi-asserted-by":"crossref","first-page":"18448","DOI":"10.7448\/IAS.16.1.18448","article-title":"Effect of concurrent use of anti-retroviral therapy and levonorgestrel sub-dermal implant for contraception on CD4 counts: a prospective cohort study in Kenya","volume":"16","author":"Hubacher","year":"2013","journal-title":"J Int AIDS Soc"},{"issue":"6","key":"10.1016\/j.contraception.2015.07.003_bb0035","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.contraception.2012.05.001","article-title":"Effect of injectable contraceptive use on response to antiretroviral therapy among women in Rakai, Uganda","volume":"86","author":"Polis","year":"2012","journal-title":"Contraception"},{"issue":"9","key":"10.1016\/j.contraception.2015.07.003_bb0040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/aje\/kwi116","article-title":"Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy","volume":"161","author":"Chu","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2015.07.003_bb0045","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/01.aids.0000363777.76129.b4","article-title":"Determinants of contraceptive choice among women with HIV","volume":"23","author":"Whiteman","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2015.07.003_bb0050","series-title":"Medical Eligibility for Contraceptive Use: Fourth Edition, 2009","author":"World Health Organization","year":"2010"},{"issue":"2","key":"10.1016\/j.contraception.2015.07.003_bb0055","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(02)01169-5","article-title":"Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy","volume":"113","author":"Cohen","year":"2002","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.contraception.2015.07.003_bb0060","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/QAD.0b013e32833b3282","article-title":"Effect of hormonal contraceptive use on HIV progression in female HIV seroconverters in Rakai, Uganda","volume":"24","author":"Polis","year":"2010","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.contraception.2015.07.003_bb0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/QAI.0b013e318214ba4a","article-title":"Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe","volume":"57","author":"Morrison","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.contraception.2015.07.003_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/380974","article-title":"Injectable contraceptive use and genital ulcer disease during the early phase of HIV-1 infection increase plasma virus load in women","volume":"189","author":"Lavreys","year":"2004","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.contraception.2015.07.003_bb0075","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/315469","article-title":"Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand","volume":"181","author":"Kilmarx","year":"2000","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.contraception.2015.07.003_bb0080","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/01.aids.0000363779.65827.e0","article-title":"Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative","volume":"23","author":"Stringer","year":"2009","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.contraception.2015.07.003_bb0085","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/00002030-200307250-00019","article-title":"Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women","volume":"17","author":"Cejtin","year":"2003","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.contraception.2015.07.003_bb0090","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/QAD.0b013e328032790f","article-title":"Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women","volume":"21","author":"Richardson","year":"2007","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.contraception.2015.07.003_bb0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1089\/jwh.2006.0151","article-title":"Pregnancy, hormonal contraceptive use, and HIV-related death in Rwanda","volume":"16","author":"Allen","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.contraception.2015.07.003_bb0100","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/sti.75.4.247","article-title":"Survival and progression of HIV disease in women attending GUM\/HIV clinics in Britain and Ireland","volume":"75","author":"Study Group for the MRC Collaborative Study","year":"1999","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.contraception.2015.07.003_bb0105","series-title":"World Health Organization, Hormonal Contraceptive Methods for Women at High Risk for HIV and Living with HIV 2014 Guidance Statement","year":"2014"},{"issue":"1","key":"10.1016\/j.contraception.2015.07.003_bb0110","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/169.1.28","article-title":"Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring","volume":"169","author":"Hughes","year":"1994","journal-title":"J Infect Dis"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241500476X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001078241500476X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T08:28:58Z","timestamp":1617438538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001078241500476X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S001078241500476X"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.07.003","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}